Abiopharma

News list

Director Zhang Yi 🟡 adjusted position in 0 shares (1 derivative) of H World Group Ltd (HTHT) Transaction Date: Aug 15, 2026 | Filing ID: 098082

Full text

News bot Aug. 18, 2026, 10:34 a.m.
🔍 Zhang Yi (Director)

Company: H World Group Ltd (HTHT)

Report Date: 2026-08-15
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 65,620
- Total shares sold: 65,620
Detailed Transactions and Holdings:
- Acquired 65,620 shares of Ordinary Shares (Direct)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 65,620.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 65,620 shares of Restricted Share Units (Derivative)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 196,860.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
Footnotes:
- F1: Reflects restricted share units that vested and settled into ordinary shares.
- F2: Each restricted share unit represents the right to receive one ordinary share.
- F3: These restricted share units were granted on August 5, 2025 and vested on August 15, 2026. These restricted share units were previously reported on the Form 3 filed by the Reporting Person on March 13, 2026.